Sell Cineplex (TSX:CGX) NOW and Buy This Top Stock Instead

Cineplex (TSX:CGX) looks poised to disappoint in a brutal environment, while investors should turn their attention to another form of entertainment.

| More on:
Dice engraved with the words buy and sell

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In late July, I’d recommended that TSX investors stay away from stocks in struggling sectors. Cineplex (TSX:CGX) was one of the stocks I’d discussed at the time. As grim as the situation has been for movie theatres, the stock did manage to gain momentum in late August. Today, I want to discuss why investors should give up on this stock and seek out another promising equity instead.

Why you should sell Cineplex right now

Shares of Cineplex fell 2.52% on September 3. The company released its second-quarter 2020 results on August 14. Predictably, revenues and customer traffic took a dive. It was forced to cease cinema operations in the middle of March. This last into late August. Now, Cineplex has managed to open all its locations across Canada. However, they must operate at a limited capacity.

In the past, Cineplex offered a hefty monthly dividend that investors could count on. The COVID-19 pandemic forced the company to halt its dividend offering. This means the stock is only valuable to those hoping to take advantage of a price rebound going forward. Big releases are on tap in the final months of 2020. Many Canadian consumers still lack enthusiasm with the pandemic in the back of their minds. Investors should expect home entertainment options to continue to draw eyeballs away from the theatre.

Worse, Cineplex currently possesses a high level of debt, and it needs to fight its way back to profitability. There just aren’t many good reasons to keep betting on Canada’s top theatre company today.

This “sin stock” offers a different kind of entertainment

A “sin stock” is an equity connected to industries like alcohol, cannabis, and gambling. So-called sin industries have historically been reliable, even during tough economic periods. Pollard Banknote (TSX:PBL) manufactures and sells a range of gaming products and services for the lottery and charitable gaming industries around the world.

Shares of Pollard have dropped 6.4% in 2020 as of close on September 3. The stock is up 17% month over month. Pollard released its second-quarter results on August 12. Unlike Cineplex, Pollard performed very well in the face of the COVID-19 pandemic.

In the early weeks of the pandemic, from mid-March to mid-April, the lottery market experienced a decline in retail sales of instant tickets. Sales activity has bounced back significantly in this space. The lottery industry has also moved into the e-commerce space, which has provided a boost to activity. Since the beginning of May, retail sales have climbed by roughly 20-25% compared to the previous year.

Total adjusted EBITDA rose to $19.8 million in Q2 2020 compared to $13.6 million in the prior year. Meanwhile, in the year-to-date period, adjusted EBITDA increased to $35.8 million over $30 million in the first six months of 2019.

Pollard stock last possessed a price-to-earnings ratio of 28 and a price-to-book value of 3.7. This puts the stock in average value territory relative to industry peers. There is a lot to like about the spike in lottery sales activity when it relates to this company. I’m still bullish on its chances going forward, especially compared to Cineplex.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »